These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 13148527)

  • 21. Studies on the development of resistance of tubercle bacilli to isoniazid.
    VENNESLAND K
    Trans Annu Meet Natl Tuberc Assoc; 1953; 49():183-91. PubMed ID: 13136314
    [No Abstract]   [Full Text] [Related]  

  • 22. The chemotherapeutic agents and the resistance against tubercle bacilli. I. The inactivation and the tuberculocidal effect of isoniazid.
    SHOJI M
    Sci Rep Res Inst Tohoku Univ Med; 1955 Jan; 6(1):97-106. PubMed ID: 13246660
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on isoniazid and tubercle bacilli. II. The growth requirements, catalase activities, and pathogenic properties of isoniazid-resistant mutants.
    COHN ML; KOVITZ C; ODA U; MIDDLEBROOK G
    Am Rev Tuberc; 1954 Oct; 70(4):641-64. PubMed ID: 13197742
    [No Abstract]   [Full Text] [Related]  

  • 24. Haeminisoniazid interaction and the effect of haemin in reviving isoniazid-treated tubercle bacilli.
    KNOX R; WOODROFFE RC
    Br J Exp Pathol; 1955 Aug; 36(4):425-31. PubMed ID: 13250119
    [No Abstract]   [Full Text] [Related]  

  • 25. Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.
    MIDDLEBROOK G
    Am Rev Tuberc; 1954 Mar; 69(3):471-2. PubMed ID: 13138881
    [No Abstract]   [Full Text] [Related]  

  • 26. Attenuation of highly isoniazid-resistant tubercle bacilli.
    HIRANO N; NAKANISHI K; FUKUNAGA K
    Yokohama Med Bull; 1955 Aug; 6(4):196-202. PubMed ID: 13300158
    [No Abstract]   [Full Text] [Related]  

  • 27. A new method for determining the growth rate of M. tuberculosis and its application to the study of the toxic effect of streptomycin and isonicotinic hydrazide acid on tubercle bacilli.
    BEKIERKUNST A; SZULGA T
    Schweiz Z Pathol Bakteriol; 1954; 17(1):47-72. PubMed ID: 13156590
    [No Abstract]   [Full Text] [Related]  

  • 28. The influence of isoniazid and streptomycin on acid-fastness, tetrazolium reduction, growth, and survival of tubercle bacilli.
    KOCH-WESER D; BARCLAY WR; EBERT RH
    Am Rev Tuberc; 1955 Apr; 71(4):556-65. PubMed ID: 14361969
    [No Abstract]   [Full Text] [Related]  

  • 29. [Congruence of resistance of tubercle bacilli to rimifon in the test tube and in animal experiment].
    FUST B; STUDER A; BOHNI E
    Schweiz Z Tuberk; 1953; 10(4):328-33. PubMed ID: 13135500
    [No Abstract]   [Full Text] [Related]  

  • 30. Susceptibility to isoniazid and pathogenicity of tubercle bacilli.
    BLOCH H; WIDELOCK D; PEIZER LR
    Am Rev Tuberc; 1953 Nov; 68(5):734-8. PubMed ID: 13104886
    [No Abstract]   [Full Text] [Related]  

  • 31. Virulence for guinea pigs of tubercle bacilli isolated from pulmonary lesions resected during chemotherapy.
    KAZLOWSKI JP; BROSBE E; RALEIGH JW; BERNSTEIN S
    Am Rev Tuberc; 1956 Feb; 73(2):266-75. PubMed ID: 13283265
    [No Abstract]   [Full Text] [Related]  

  • 32. The bactericidal action of isoniazid, streptomycin and terramycin on extracellular and intracellular tubercle bacilli.
    MACKANESS GB; SMITH N
    Am Rev Tuberc; 1953 Mar; 67(3):322-40. PubMed ID: 13031052
    [No Abstract]   [Full Text] [Related]  

  • 33. Slide culture of tubercle bacilli. II. In vitro sensitivity testing.
    REED RW
    Can J Microbiol; 1954 Aug; 1(1):30-5. PubMed ID: 14352036
    [No Abstract]   [Full Text] [Related]  

  • 34. Developments in the laboratory: the growth requirements and pathogenic properties of isoniazid-resistant tubercle bacilli.
    MIDDLEBROOK G; COHN ML; SCHAEFER WB; KOVITZ C
    Trans Annu Meet Natl Tuberc Assoc; 1954; 96(50th Meeting):239-40. PubMed ID: 13216871
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients.
    MIDDLEBROOK G; COHN ML; SCHAEFER WB
    Am Rev Tuberc; 1954 Nov; 70(5):852-72. PubMed ID: 13207636
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental studies on chemotherapy of tuberculosis. II. Problem of virulence changes of tubercle bacilli after prolonged chemotherapeutic treatment].
    VELTMAN G
    Zentralbl Bakteriol Orig; 1955 Jun; 163(2-3):210-8. PubMed ID: 13257661
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathogenicity of isoniazid-resistant tubercle bacilli and prophylaxis of tuberculosis in children.
    RIST N
    Am Rev Tuberc; 1956 Aug; 74(2 Part 2):75-89; discussion, 90-9. PubMed ID: 13340168
    [No Abstract]   [Full Text] [Related]  

  • 38. Varied degrees of isoniazid resistance within strains of tubercle bacilli from sputum and pulmonary cavities.
    STEWART SM
    Am Rev Tuberc; 1956 Mar; 73(3):390-405. PubMed ID: 13292708
    [No Abstract]   [Full Text] [Related]  

  • 39. The chemotherapeutic agents and their resistance against tubercle bacilli. III. Hemin starch liquid medium for the cultivation of isoniazid-susceptible and resistant tubercle bacilli.
    SHOJI M
    Sci Rep Res Inst Tohoku Univ Med; 1955 Oct; 6(3):377-90. PubMed ID: 13298725
    [No Abstract]   [Full Text] [Related]  

  • 40. Growth characteristics, virulence, and cytochemical properties of tubercle bacilli recovered from patients treated with isoniazid.
    PATNODE RA; DAIL MC; HUDGINS PC
    Am J Public Health Nations Health; 1955 Apr; 45(4):451-6. PubMed ID: 14361793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.